DOP41 Low-grade dysplasia prognosis and predictive factors for advanced neoplasia progression in the 21st century: A large multi-centre retrospective cohort study
ECCO'20 Vienna
2020
DOP42 Impact of discontinuing thiopurines at anti-TNF initiation in inflammatory bowel disease: A nationwide Danish cohort study
ECCO'20 Vienna
2020
DOP43 The risk of extra-intestinal cancer in inflammatory bowel disease (IBD): A systematic review and meta-analysis of population-based cohort studies
ECCO'20 Vienna
2020
DOP44 Cancer risk in a high-incidence inflammatory bowel disease population: a Faroese IBD cohort study
ECCO'20 Vienna
2020
DOP45 Increased prevalence but not incidence of myocardial infarction and stroke in patients with inflammatory bowel diseases in Quebec in 1996–2015
ECCO'20 Vienna
2020
DOP46 Impact of a genetic burden on familial aggregation of inflammatory bowel disease
ECCO'20 Vienna
2020
DOP47 The changing pattern of inflammatory bowel disease incidence in Northern France: A continuing increase in the young women (1988–2014)
ECCO'20 Vienna
2020
DOP48 Gene expression landscape of epithelial monolayer in inflammatory bowel disease
ECCO'20 Vienna
2020
DOP49 Quantitative proteomics analysis of macrophages from Crohn’s disease patients and infected with adherent-invasive Escherichia coli
ECCO'20 Vienna
2020
DOP51 Investigation on the role of Par4-associated cell polarity and associated barrier defects in inflammatory bowel diseases
ECCO'20 Vienna
2020
DOP54 Integrated network analysis using patient-specific single-nucleotide polymorphism profiles uncovers new pathways involved in ulcerative colitis pathogenesis
ECCO'20 Vienna
2020
DOP57 Vedolizumab has similar efficacy rates in young and elderly patients: A binational, multicentre, retrospective case–control study
ECCO'20 Vienna
2020